Rebalance: Compassion Focused Therapy in a Transdiagnostic Health Group
Launched by UNIVERSITY OF EDINBURGH · Jul 30, 2019
Trial Information
Current as of August 25, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Experiencing difficulties adjusting to one or more chronic physical health condition(s)
- • Willing and motivated to attend a nine-week group facilitated in English
- • Exhibit sufficient interpersonal skills and impulse control to allow them to engage with group members without disrupting group dynamics
- • Able to provide informed consent
- Exclusion Criteria:
- • Moderate or severe impairment of cognitive function
- • Primary problem related to drug or alcohol misuse
- • Actively suicidal or experiencing an acute deterioration in their mental health including experiencing an acute psychotic episode
About University Of Edinburgh
The University of Edinburgh, a prestigious institution renowned for its commitment to research excellence and innovation, serves as a leading clinical trial sponsor dedicated to advancing healthcare through rigorous scientific inquiry. With a strong emphasis on multidisciplinary collaboration, the university facilitates cutting-edge clinical studies that aim to explore novel therapies and improve patient outcomes. Leveraging its extensive network of researchers, healthcare professionals, and state-of-the-art facilities, the University of Edinburgh is at the forefront of translating scientific discoveries into practical applications, thereby contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Edinburgh, , United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials